Jarle Aarbakke
- Public Health, Environmental and Occupational Health top 2%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 2%
- Oncology top 10%
- Pharmacology top 1%
- Co-authors
- B. KlemetsdalLars SlørdalThrina LoennechenJeong Ok Park-HahPetter Cappelen EndresenGertrude B. ElionGritta Janka‐SchaubRoy M. Bremnes
- Topics
- Acute Lymphoblastic Leukemia research (36 papers)Childhood Cancer Survivors' Quality of Life (12 papers)Chronic Myeloid Leukemia Treatments (12 papers)
- Journals
- EndocrinologyJournal of Pharmacology and Experimental TherapeuticsTrends in Pharmacological Sciences
- Partner nations
- NorwayUnited StatesSingapore
In The Last Decade
Jarle Aarbakke
108 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 121
- Public Health, Environmental and Occupational Health 825
- Molecular Biology 602
- Pediatrics, Perinatology and Child Health 466
- Oncology 290
- Pharmacology 274
Countries citing papers authored by Jarle Aarbakke
This map shows the geographic impact of Jarle Aarbakke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarle Aarbakke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarle Aarbakke more than expected).
Fields of papers citing papers by Jarle Aarbakke
This network shows the impact of papers produced by Jarle Aarbakke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarle Aarbakke. The network helps show where Jarle Aarbakke may publish in the future.
Co-authorship network of co-authors of Jarle Aarbakke
This figure shows the co-authorship network connecting the top 25 collaborators of Jarle Aarbakke. A scholar is included among the top collaborators of Jarle Aarbakke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarle Aarbakke. Jarle Aarbakke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Individuelt tilpasset legemiddelbehandling | 0 |
| 2 | 6 | |
| 3 | 27 | |
| 4 | 317 | |
| 5 | 11 | |
| 6 | 96 | |
| 7 | [Injuries and drug use among soccer players]. | 2 |
| 8 | 37 | |
| 9 | 4 | |
| 10 | 49 | |
| 11 | 11 | |
| 12 | 16 | |
| 13 | 8 | |
| 14 | 21 | |
| 15 | 4 | |
| 16 | 5 | |
| 17 | 4 | |
| 18 | 3 | |
| 19 | Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo. | 38 |
| 20 | 12 |
About Jarle Aarbakke
Jarle Aarbakke is a scholar working on Pharmacology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health, having authored 111 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (36 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). The work is most often cited by research in Pharmacology (274 citations), Public Health, Environmental and Occupational Health (825 citations) and Transplantation (72 citations). Jarle Aarbakke has collaborated with scholars based in Norway, United States and Singapore. Frequent co-authors include B. Klemetsdal, Lars Slørdal, Thrina Loennechen, Jeong Ok Park-Hah, Petter Cappelen Endresen, Gertrude B. Elion, Gritta Janka‐Schaub, Roy M. Bremnes, Lisbeth Aasmoe and Earl L. Branum. Their work appears in journals such as Endocrinology, Journal of Pharmacology and Experimental Therapeutics and Trends in Pharmacological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.